Citigroup »

Lenz Therapeutics shares owned by Citigroup

Quarter-by-quarter ownership of Lenz Therapeutics (LENZ) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Lenz Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lenz Therapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lenz Therapeutics by Citigroup

Quarter filed Position value Share count Share price at filing
2024-06-30 $319k 19k 17.29
2024-03-31 $17k 750 22.33

More positions owned by Citigroup

Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Russell 2000 Etf (IWM)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Ishares Tr Msci Emg Mkt Etf (EEM)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Tesla Motors (TSLA)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Spdr Gold Tr Gold Shs (GLD)

View all positions for Citigroup

Top funds holding Lenz Therapeutics

RA Capital Management
Falcon Edge Capital
EcoR1 Capital
Samsara BioCapital
72 Investment Holdings
BlackRock
Vanguard Group
Point72 Asset Management
Tang Capital Management
Geode Capital Management
Alyeska Investment Group
State Street Corporation
Ikarian Capital
Board of Trustees of The Leland Stanford Junior University
Wealth Enhancement Advisory Services

View all funds holding Lenz Therapeutics